mhurhangee/ep-ind-claims huggingface dataset:
A method for operating a security tag, comprising: converting rotational motion of a pinion gear in a first direction into linear motion of a rack gear in a second direction so as to cause a pin to transition from an unengaged state in which the pin is retracted into a first portion of an enclosure to an engaged state in which an end of the pin resides within an aperture formed in a second portion of the enclosure spaced apart from the first portion of the enclosure by a gap; mechanically retaining the pin in the engaged position using a pawl that prevents movement of the pinion gear in a third direction opposed to the first direction; and automatically releasing the pawl in response to a reception of a wireless signal at the security tag sent from a remote external device, whereby the pin returns to the unengaged state in which the pin is retracted into the first portion of the enclosure. converting rotational motion of a pinion gear in a first direction into linear motion of a rack gear in a second direction so as to cause a pin to transition from an unengaged state in which the pin is retracted into a first portion of an enclosure to an engaged state in which an end of the pin resides within an aperture formed in a second portion of the enclosure spaced apart from the first portion of the enclosure by a gap; mechanically retaining the pin in the engaged position using a pawl that prevents movement of the pinion gear in a third direction opposed to the first direction; and automatically releasing the pawl in response to a reception of a wireless signal at the security tag sent from a remote external device, whereby the pin returns to the unengaged state in which the pin is retracted into the first portion of the enclosure.
An arrangement of individual seats to be installed in an aircraft cabin, comprising at least one module of two seats (13.1, 13.3) facing each other, said module having a longitudinal direction of extension, said arrangement further comprising: - a console (27.1) arranged between the two seats (13.1, 13.3) of the module, - a screen associated with each seat (13.1, 13.3), each screen being mounted on a screen support, characterized in that: - the screen supports are movable between a stowed position of use and a deployed position of use in which the screen supports are positioned substantially edge to edge and form a partition wall between the two seats (13.1, 13.3) facing each other. - a console (27.1) arranged between the two seats (13.1, 13.3) of the module, - a screen associated with each seat (13.1, 13.3), each screen being mounted on a screen support, characterized in that: - the screen supports are movable between a stowed position of use and a deployed position of use in which the screen supports are positioned substantially edge to edge and form a partition wall between the two seats (13.1, 13.3) facing each other.
Apparatus for collecting balls, for example, tennis balls, golf balls, etcetera, having at least two pipe elements (2a, 2b), wherein the pipe elements (2a, 2b) can be assembled in order to form a base member, wherein the base member has an introduction opening for the balls, wherein the pipe elements (2a, 2b) in each case have a written and/or visual part-information item (4a, 4b) and wherein the part-information items (4a, 4b) in the assembled state of the pipe elements (2a, 2b) form an overall information item, wherein the apparatus in addition enables the overall information item to be transmitted when the pipe elements (2a, 2b) are assembled and the apparatus is consequently in a position for use, wherein the part-information items (4a, 4b) are printed on the pipe elements (2a, 2b) and/or an information element which carries the part-information item (4a, 4b) is arranged on the pipe elements (2a, 2b).
A method for manufacturing a negative electrode, the method comprising: immersing a preliminary negative electrode, which comprises (a) a current collector and (b) on the current collector, a preliminary negative electrode active material layer comprising a negative electrode active material, in a pre-lithiation solution for 5 hours to 48 hours, said pre-lithiation solution comprising a lithium organic compound at a concentration of 0.09 M to 1.00 M and a pre-lithiation solvent, wherein a standard reduction potential of the lithium organic compound is lower than a standard reduction potential of the negative electrode active material; and taking the preliminary negative electrode out of the pre-lithiation solution and then removing pre-lithiation solvent present in the preliminary negative electrode, the removing of pre-lithiation solvent comprising washing and drying the preliminary negative electrode. immersing a preliminary negative electrode, which comprises (a) a current collector and (b) on the current collector, a preliminary negative electrode active material layer comprising a negative electrode active material, in a pre-lithiation solution for 5 hours to 48 hours, said pre-lithiation solution comprising a lithium organic compound at a concentration of 0.09 M to 1.00 M and a pre-lithiation solvent, wherein a standard reduction potential of the lithium organic compound is lower than a standard reduction potential of the negative electrode active material; and taking the preliminary negative electrode out of the pre-lithiation solution and then removing pre-lithiation solvent present in the preliminary negative electrode, the removing of pre-lithiation solvent comprising washing and drying the preliminary negative electrode.
A process for preparing a drug substance of a vaccine containing as an active ingredient attenuated vaccinia virus LC16m8 strain with a content ratio of revertant being 3% or less, which comprises the following steps to or to: Inoculating a solution of the LC16m8 strain at such a range of MOI as to avoid contamination of revertants (MSP strain) to 1 to n containers, wherein n is an integer, of animal cells and incubating them; Diluting a portion of the cultured solution from each container and inoculating the diluted solution to RK-13 cells and to Vero cells at a viral content of 1 x 10 4 PFU or more and incubating them; Selecting containers which contain a cultured solution that forms plaques in RK-13 cells but does not form plaques in Vero cells and collecting and pooling each viral solution from the cells and/or cultured solution obtained from selected containers; Inoculating the pooled viral solution obtained in to animal cells at a MOI of 0.1 to 1 and collecting a viral solution from the cells and/or cultured solution; and Inoculating the collected viral solution and/or cultured solution, obtained in to animal cells at a MOI of 0.1 to 1, incubating the cells, and collecting a viral solution from the cells and/or culture solution. Inoculating a solution of the LC16m8 strain at such a range of MOI as to avoid contamination of revertants (MSP strain) to 1 to n containers, wherein n is an integer, of animal cells and incubating them; Diluting a portion of the cultured solution from each container and inoculating the diluted solution to RK-13 cells and to Vero cells at a viral content of 1 x 10 4 PFU or more and incubating them; Selecting containers which contain a cultured solution that forms plaques in RK-13 cells but does not form plaques in Vero cells and collecting and pooling each viral solution from the cells and/or cultured solution obtained from selected containers; Inoculating the pooled viral solution obtained in to animal cells at a MOI of 0.1 to 1 and collecting a viral solution from the cells and/or cultured solution; and Inoculating the collected viral solution and/or cultured solution, obtained in to animal cells at a MOI of 0.1 to 1, incubating the cells, and collecting a viral solution from the cells and/or culture solution.
An end cover assembly, used for a battery cell, comprising: a cover plate provided with a pressure relief hole; a fixing member fixed on the cover plate, the fixing member having a first through hole and a second through hole, and the first through hole being opposite to the pressure relief hole; and a gas permeable membrane covering at least a portion of the pressure relief hole, an edge part of the gas permeable membrane being connected to the fixing member, and a portion of the edge part being embedded into the second through hole, so as to prevent the edge part from moving relative to the fixing member; characterized in that a gap along a thickness direction of the cover plate is formed between the fixing member and the cover plate, or the fixing member has a gap along the thickness direction of the cover plate; and the edge part comprises a first portion and a second portion, the first portion extends into the gap, the second portion is connected to the first portion, and the second portion is embedded into the second through hole. a cover plate provided with a pressure relief hole; a fixing member fixed on the cover plate, the fixing member having a first through hole and a second through hole, and the first through hole being opposite to the pressure relief hole; and a gas permeable membrane covering at least a portion of the pressure relief hole, an edge part of the gas permeable membrane being connected to the fixing member, and a portion of the edge part being embedded into the second through hole, so as to prevent the edge part from moving relative to the fixing member; characterized in that a gap along a thickness direction of the cover plate is formed between the fixing member and the cover plate, or the fixing member has a gap along the thickness direction of the cover plate; and the edge part comprises a first portion and a second portion, the first portion extends into the gap, the second portion is connected to the first portion, and the second portion is embedded into the second through hole.
A retroviral particle comprising a protein coming from the Gag polyprotein, an envelope protein, optionally an integrase and at least two different encapsidated non-viral RNAs, the different encapsidated non-viral RNAs each comprising an RNA sequence of interest linked to an encapsidation sequence, each encapsidation sequence being recognized by a binding domain introduced into the protein coming from the Gag polyprotein.
A composite osteoimplant for use in implantation into a tissue site, the composite osteoimplant comprising: a polymer selected from the group consisting of starch poly (caprolactone), poly (caprolactone), poly (l-lactide), poly (dl-lactide-co-glycolide), poly (l-lactide-co-dl-lactide), enantiomers of the above, co-polymers of the above, and mixtures of the above; and bone-derived particles, wherein at least a portion of the bone-derived particles in the composite osteoimplant are elongate and possess a median length to median thickness ratio of at least 50: 1 up to 500: 1 or more and a median length to median width ratio from 10: 1 to 200: 1, wherein the composite osteoimplant is formed immediately prior to implantation by hand or using hand-held tools to a predetermined shape, after heating to a first predetermined condition being a temperature greater than 40°C, and is set under a second predetermined condition, wherein the composite osteoimplant is not formable at 37°C, and wherein the composite osteoimplant becomes formable when heated to the first predetermined condition being a temperature greater than 40°C. a polymer selected from the group consisting of starch poly (caprolactone), poly (caprolactone), poly (l-lactide), poly (dl-lactide-co-glycolide), poly (l-lactide-co-dl-lactide), enantiomers of the above, co-polymers of the above, and mixtures of the above; and bone-derived particles, wherein at least a portion of the bone-derived particles in the composite osteoimplant are elongate and possess a median length to median thickness ratio of at least 50: 1 up to 500: 1 or more and a median length to median width ratio from 10: 1 to 200: 1, wherein the composite osteoimplant is formed immediately prior to implantation by hand or using hand-held tools to a predetermined shape, after heating to a first predetermined condition being a temperature greater than 40°C, and is set under a second predetermined condition, wherein the composite osteoimplant is not formable at 37°C, and wherein the composite osteoimplant becomes formable when heated to the first predetermined condition being a temperature greater than 40°C.
A tracheal device usable for the assisted respiration of a patient, comprising: - at least a first tube, having a proximal end to be arranged protruding from the mouth of the patient and connectable to an assisted respiration device, and a distal end usable to cover an orifice; - at least a first sealing element externally coupled to said first tube; - at least a second tube having the distal end usable to cover an orifice; - at least a second sealing element externally coupled to said second tube; said tracheal device being characterized in comprising at least one flexible and collapsible service duct stably coupled to said first tube and said second tube to allow said duct and said tubes ( 2, 14) to be arranged in a first configuration in which said distal end of said first tube is inserted into the supraglottic region of the patient and said distal end of said second tube is inserted into the oesophagus of the patient, and in a second configuration in which said distal end of said first tube is inserted into the trachea of the patient and said distal end of said second tube is inserted into the oesophagus of the patient. - at least a first tube, having a proximal end to be arranged protruding from the mouth of the patient and connectable to an assisted respiration device, and a distal end usable to cover an orifice; - at least a first sealing element externally coupled to said first tube; - at least a second tube having the distal end usable to cover an orifice; - at least a second sealing element externally coupled to said second tube;
A medical device comprising: a structure made of one biodegradable and/or bioabsorbable material; a degradation additive encapsulated by another biodegradable and/or bioabsorbable material forming a nanoparticle or microparticle, the nanoparticle or microparticle being together with the one biodegradable and/or bioabsorbable material of the structure; the other biodegradable and/or bioabsorbable material of the nanoparticle or microparticle having a degradation rate that is faster than a degradation rate of the one biodegradable and/or bioabsorbable material, the structure experiencing a period of accelerated degradation upon release of the degradation additive from the nanoparticle or microparticle, and wherein the degradation additive accelerates degradation of the structure of the medical device. a structure made of one biodegradable and/or bioabsorbable material; a degradation additive encapsulated by another biodegradable and/or bioabsorbable material forming a nanoparticle or microparticle, the nanoparticle or microparticle being together with the one biodegradable and/or bioabsorbable material of the structure; the other biodegradable and/or bioabsorbable material of the nanoparticle or microparticle having a degradation rate that is faster than a degradation rate of the one biodegradable and/or bioabsorbable material, the structure experiencing a period of accelerated degradation upon release of the degradation additive from the nanoparticle or microparticle, and wherein the degradation additive accelerates degradation of the structure of the medical device.
Use of at least one polysaccharide selected from the group consisting of trehalose, hydroxyethylstarch and dextran as a mammalian stem cell aggregation inhibitor in a mammalian stem cell suspension, wherein, - when the polysaccharide is trehalose, the inhibitor is used such that the concentration of trehalose in the mammalian stem cell suspension is within the range of 4.53 - 362.4 mg/ml; - when the polysaccharide is hydroxyethylstarch, the inhibitor is used such that the concentration of hydroxyethylstarch in the mammalian stem cell suspension is within the range of 1 - 500 mg/ml; - and when the polysaccharide is dextran, the inhibitor is used such that the concentration of dextran in the mammalian stem cell suspension is within the range of 30 - 100 mg/ml. - when the polysaccharide is trehalose, the inhibitor is used such that the concentration of trehalose in the mammalian stem cell suspension is within the range of 4.53 - 362.4 mg/ml; - when the polysaccharide is hydroxyethylstarch, the inhibitor is used such that the concentration of hydroxyethylstarch in the mammalian stem cell suspension is within the range of 1 - 500 mg/ml; - and when the polysaccharide is dextran, the inhibitor is used such that the concentration of dextran in the mammalian stem cell suspension is within the range of 30 - 100 mg/ml.
A compound of formula I in which R 1 represents phenyl, X represents the group represents or a salt thereof, particularly a physiologically acceptable salt thereof. R 1 represents phenyl, X represents the group represents
A screen intake apparatus disposed in a body of water, the apparatus comprising: a screen (210, 300) having an exterior exposed to the body of water and defining an interior in fluid communication with a water intake, the screen (210, 300) screening passage of the water from the body to the water intake; means for pumping the cleaning liquid for delivery to the interior of the screen (210, 300); means for delivering pumped cleaning liquid to the interior of the screen (210, 300); means for pulsing flow of the pumped cleaning fluid for delivery to the interior of the screen (210,300) including a controllable flow device; a controller for controlling both the means for pumping and the means for pulsing flow of the pumped cleaning fluid liquid; and means for directing (112, 120) the delivered cleaning liquid within the interior of the screen (210, 300). a screen (210, 300) having an exterior exposed to the body of water and defining an interior in fluid communication with a water intake, the screen (210, 300) screening passage of the water from the body to the water intake; means for pumping the cleaning liquid for delivery to the interior of the screen (210, 300); means for delivering pumped cleaning liquid to the interior of the screen (210, 300); means for pulsing flow of the pumped cleaning fluid for delivery to the interior of the screen (210,300) including a controllable flow device; a controller for controlling both the means for pumping and the means for pulsing flow of the pumped cleaning fluid liquid; and means for directing (112, 120) the delivered cleaning liquid within the interior of the screen (210, 300).
A method of making a capsule formulation suitable for desensitization of peanut allergy comprising, (a) mixing peanut flour with diluent, glidant and lubricant; (b) discharging the blended material; (c) passing the blended material through a mesh screen; and (d) encapsulating the blended powder; wherein: - the capsule comprises 0.5 mg, 1 mg, 10 mg, 100 mg, 475 mg or 1000 mg of peanut protein; - the capsule may be opened and the content mixed into taste-masking food immediately prior to administration; - the peanut flour comprises the peanut proteins Ara h1, Ara h2 and Ara h6, and - the proportion of Ara h1, Ara h2 and Ara h6 is controlled. (a) mixing peanut flour with diluent, glidant and lubricant; (b) discharging the blended material; (c) passing the blended material through a mesh screen; and (d) encapsulating the blended powder; - the capsule comprises 0.5 mg, 1 mg, 10 mg, 100 mg, 475 mg or 1000 mg of peanut protein; - the capsule may be opened and the content mixed into taste-masking food immediately prior to administration; - the peanut flour comprises the peanut proteins Ara h1, Ara h2 and Ara h6, and - the proportion of Ara h1, Ara h2 and Ara h6 is controlled.
An awning arm comprising an elbow which comprises two caps and, between said caps, a connection element connecting said caps, characterized in that the connection element comprises: - A central body formed by a diabolo, that is, two cones linked by its vertex, with the bases of the cones opposite, and - A spindle placed in each base perpendicularly thereto. - A central body formed by a diabolo, that is, two cones linked by its vertex, with the bases of the cones opposite, and - A spindle placed in each base perpendicularly thereto.
- Cooking appliance, comprising: • an induction hob arranged for receiving a cooking vessel; • a power unit configured for supplying electric power to the induction hob; • a control unit configured for regulating the electric power being supplied by the power unit; and • a temperature control device configured for communicating with the control unit, allowing regulation of the electric power being supplied by the power unit according to the values of a first and second temperature (T 1, T 2), comprising a first temperature probe fitted to be fixed to the cooking vessel and having a first temperature sensor configured for measuring a first temperature (T 1) directly associated to a cooking medium contained within the cooking vessel, wherein the first temperature sensor is configured for being submerged into the cooking medium; said appliance being characterized in that the temperature control device further comprises a second temperature probe having a second temperature sensor configured for measuring a second temperature (T 2) directly associated to a food which is dipped into the cooking medium, wherein the second temperature sensor is configured for being stuck into the food. • an induction hob arranged for receiving a cooking vessel; • a power unit configured for supplying electric power to the induction hob; • a control unit configured for regulating the electric power being supplied by the power unit; and • a temperature control device configured for communicating with the control unit, allowing regulation of the electric power being supplied by the power unit according to the values of a first and second temperature (T 1, T 2), comprising a first temperature probe fitted to be fixed to the cooking vessel and having a first temperature sensor configured for measuring a first temperature (T 1) directly associated to a cooking medium contained within the cooking vessel, wherein the first temperature sensor is configured for being submerged into the cooking medium;
Seal carrier for a turbomachine, in particular a gas turbine, comprising a carrier base and at least one sealing body, wherein the at least one sealing body is connected to the carrier base and the at least one sealing body is formed by a plurality of cavities arranged next to one another in the circumferential direction and in the axial direction, in particular regularly, wherein the cavities extend from the carrier base in the radial direction, wherein at least one stiffening element (24, 24a) which extends along the circumferential direction is provided on the carrier base, which stiffening element at least partially covers the at least one sealing body at one of the axial end regions thereof, wherein the carrier base, the at least one sealing body and the at least one stiffening element (24, 24a) are produced by an additive manufacturing method and are formed in one piece.